Key Points
- Insider sale: Sally Massey sold 15,851 shares on Feb. 5 at an average price of $95.03 for about $1.506M, trimming her stake by 53.6% to 13,751 shares; the transaction was disclosed in an SEC filing.
- Earnings beat: Colgate reported Q4 EPS of $0.95 vs. $0.91 expected and revenue of $5.23B vs. $5.13B expected, with revenue up 5.8% year‑over‑year and a 10.45% net margin.
- Dividends & outlook: The company declared a $0.52 quarterly dividend (2.2% yield, 79.4% payout), the stock trades near $94 with a P/E around 36, and analysts maintain a near‑term "Moderate Buy" consensus price target of about $94.5.
Colgate-Palmolive Company (NYSE:CL - Get Free Report) insider Sally Massey sold 15,851 shares of the stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $95.03, for a total value of $1,506,320.53. Following the transaction, the insider owned 13,751 shares of the company's stock, valued at $1,306,757.53. The trade was a 53.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.
Colgate-Palmolive Stock Performance
Shares of CL stock opened at $94.18 on Tuesday. The firm's 50 day moving average is $82.41 and its 200 day moving average is $81.59. The stock has a market capitalization of $75.92 billion, a P/E ratio of 35.95, a PEG ratio of 4.26 and a beta of 0.29. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18. The company has a current ratio of 0.42, a quick ratio of 0.27 and a debt-to-equity ratio of 5.90.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same period in the prior year, the firm posted $0.91 earnings per share. The company's revenue for the quarter was up 5.8% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st will be issued a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive's dividend payout ratio is presently 79.39%.
Hedge Funds Weigh In On Colgate-Palmolive
Several large investors have recently modified their holdings of CL. Westside Investment Management Inc. boosted its stake in Colgate-Palmolive by 85.5% during the 2nd quarter. Westside Investment Management Inc. now owns 282 shares of the company's stock valued at $26,000 after purchasing an additional 130 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its holdings in Colgate-Palmolive by 86.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 323 shares of the company's stock valued at $26,000 after purchasing an additional 150 shares during the period. Maseco LLP purchased a new stake in Colgate-Palmolive in the fourth quarter worth about $27,000. Copia Wealth Management bought a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $29,000. Finally, Vermillion & White Wealth Management Group LLC boosted its holdings in Colgate-Palmolive by 86.1% in the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 335 shares of the company's stock worth $30,000 after buying an additional 155 shares during the period. Hedge funds and other institutional investors own 80.41% of the company's stock.
Wall Street Analysts Forecast Growth
Several analysts have weighed in on the company. Barclays raised their price target on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "equal weight" rating in a report on Tuesday, February 3rd. Weiss Ratings reissued a "hold (c)" rating on shares of Colgate-Palmolive in a research note on Wednesday, January 21st. Jefferies Financial Group raised their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a "hold" rating in a research report on Monday, February 2nd. Citigroup increased their target price on Colgate-Palmolive from $95.00 to $105.00 and gave the company a "buy" rating in a research note on Monday, February 2nd. Finally, Evercore upped their price objective on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an "outperform" rating in a research note on Monday, February 2nd. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of "Moderate Buy" and a consensus price target of $94.47.
Check Out Our Latest Report on CL
About Colgate-Palmolive
(
Get Free Report)
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company's core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
